Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar;64(2):103-106.
doi: 10.4111/icu.20230042.

Treatment strategies for the Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer

Seung-Hwan Jeong  1 , Ja Hyeon Ku  2
Affiliations
Editorial

Treatment strategies for the Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer

Seung-Hwan Jeong et al. Investig Clin Urol. 2023 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

References

    1. Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022. - PubMed
    1. Taylor J, Becher E, Steinberg GD. Update on the guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2020;125:197–205. - PubMed
    1. Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer--a current perspective. Nat Rev Urol. 2014;11:153–162. - PubMed
    1. Yates DR, Brausi MA, Catto JW, Dalbagni G, Rouprêt M, Shariat SF, et al. Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer. Eur Urol. 2012;62:1088–1096. - PubMed
    1. Dinney CP, Greenberg RE, Steinberg GD. Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin. Urol Oncol. 2013;31:1635–1642. - PubMed

Publication types

MeSH terms